Medinotec Inc. financial data

Symbol
MDNC on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
Office 202, Gezeri Building, Naif, Po Box 488083, Dubai, United Arab Emirates
State of incorporation
NV
Fiscal year end
February 28
Latest financial report
10-Q - Q4 2024 - Jan 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391 % -83.4%
Debt-to-equity 102 % +21.4%
Return On Equity 32 %
Return On Assets 15.8 %
Operating Margin 16.5 % +309%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.7M shares 0%
Common Stock, Shares, Outstanding 11.7M shares 0%
Entity Public Float 3.66M USD 0%
Common Stock, Value, Issued 11.7K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.95M USD +220%
Cost of Revenue -2.58M USD -532%
Research and Development Expense 21.5K USD +2439%
Selling and Marketing Expense -57.3K USD -169%
General and Administrative Expense -2.06M USD -5060%
Operating Income (Loss) 1.48M USD +1209%
Nonoperating Income (Expense) -191K USD +76.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.29M USD
Income Tax Expense (Benefit) 181K USD +172%
Net Income (Loss) Attributable to Parent 781K USD
Earnings Per Share, Basic 0.07 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 992K USD +1202%
Other Assets, Current 99.9K USD -21.3%
Assets, Current 4.92M USD +36.9%
Property, Plant and Equipment, Net 378K USD +10.6%
Operating Lease, Right-of-Use Asset 45.4K USD
Assets 5.36M USD +34.3%
Accounts Payable, Current 1.59K USD -99.1%
Employee-related Liabilities, Current 21.9K USD +37.3%
Liabilities, Current 1.47M USD +339%
Operating Lease, Liability, Noncurrent 20.7K USD
Liabilities 2.54M USD +32.4%
Common Stocks, Including Additional Paid in Capital 3.31M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 76.8K USD -28.2%
Stockholders' Equity Attributable to Parent 2.83M USD +36.2%
Liabilities and Equity 5.36M USD +34.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 246K USD
Net Cash Provided by (Used in) Financing Activities -542K USD -798%
Net Cash Provided by (Used in) Investing Activities -6.06K USD
Common Stock, Shares Authorized 200M shares +6.23%
Common Stock, Shares, Issued 11.7M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -290K USD -147%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.68M USD -0.08%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10.6K USD +3.99%
Deferred Tax Assets, Valuation Allowance -177K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure -99%
Deferred Tax Assets, Gross 237K USD +117%
Payments to Acquire Property, Plant, and Equipment -6.06K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 751K USD
Property, Plant and Equipment, Gross 1.64M USD -1.95%
Operating Lease, Liability, Current 28.2K USD
Deferred Income Tax Expense (Benefit) -5.57K USD +55%
Deferred Tax Assets, Operating Loss Carryforwards 17.3K USD
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -181K USD
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 3.3M USD
Preferred Stock, Shares Outstanding 0 shares
Current Federal Tax Expense (Benefit) 12.3K USD
Operating Leases, Future Minimum Payments, Due in Two Years 31.2K USD
Depreciation, Depletion and Amortization 23.2K USD +24.4%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 30.6K USD
Deferred Tax Assets, Net of Valuation Allowance 59.6K USD -45.3%
Operating Leases, Future Minimum Payments, Due in Three Years 13K USD
Operating Leases, Future Minimum Payments Due 48.9K USD
Interest Expense -223K USD +44.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares